Latest News

With this funding, the EU supports scientists at an early stage of their career. Two of a total of 408 grants have been awarded to DZHK scientists this year: Dr Gabriele G. Schiattarella from the DZHK partner site in Berlin is investigating the molecular mechanisms of heart...

Read more

16 scientists of the German Centre for Cardiovascular Research (DZHK) are among the most cited researchers worldwide and thus among the most influential experts in their field of research. The list of "Highly Cited Researchers" is published every year by the analysis company...

Read more

An overactive enzyme that causes an inherited form of high blood pressure also appears to protect against hypertension-induced cardiac damage. A team of researchers from the Max Delbrück Center, ECRC, and DZHK led by Enno Klußmann explains in the journal Circulation how this...

Read more

The NOAH – AFNET 6 trial which is conducted to evaluate the potential benefit of oral anticoagulation in patients with atrial high rate episodes (AHRE) is going to be terminated prematurely. The reason for early termination is an observed trend towards futility for efficacy...

Read more

Almost a year after a SARS-CoV-2 infection, more than half of the participants in a Frankfurt study reported heart problems, such as tachycardia, chest pain and exercise intolerance: that is, symptoms worsening after even minor exertion. A team led by Dr Valentina Puntmann and...

Read more

A pill containing aspirin and medications to lower lipids and blood pressure more effectively prevents further adverse cardiovascular events after a heart attack compared with taking the drugs separately. That's the finding of the Europe-wide SECURE study, which has now been...

Read more

Patients with heart failure frequently also suffer from atrial fibrillation. Their heart then beats irregularly and often too fast, further worsening the heart failure , which may lead to hospitalization. A study funded by the German Center for Cardiovascular Research (DZHK) is...

Read more

Patients with atrial fibrillation benefit from early rhythm-maintenance therapy. It prevents complications better than the usual treatment. This is the result of the EAST-AFNET 4 study conducted by the Atrial Fibrillation NETwork (AFNET). Analyses of various subgroups of the...

Read more

In a study conducted by the German Center for Cardiovascular Research (DZHK), scientists are investigating a heart valve replacement made of the patient's own tissue, which is unique worldwide according to the current state of knowledge. The goal is to obtain safe implants that...

Read more

For the first time, the six German Centers for Health Research (DZG) are launching a joint research program - the DZG Innovation Fund (DZGIF).

Read more